Publication: 4257

Publication: 4257

Final Report on NCCTG N0877 (Alliance): A Phase II Randomized, Placebo-Controlled Trial of Chemoradiotherapy with or without Dasatinib for Glioblastoma.

PubMed

DOI

Google Scholar

Citation:: Neuro Oncol

Year:: 2025
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub-ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 14

Parents:: 510 2278 2279
Children:: None

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA189825, UG1CA232760, UG1CA233339

Corr. Author:
Authors:: William G Breen J G Dixon S K Anderson J N Sarkaria P D Brown E S Yan S Kizilbash E Galanis Daniel Anderson David Tran Miroslaw Mazurczak Derek R Johnson F J Geoffroy Clinton Leinweber N N Laack

Networks:: HEARTLAND, LAPS-MN026, LAPS-MO011, METROMIN, MN022, NC012, SANFORD

Study: NCCTG-N0877
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords: